251 related articles for article (PubMed ID: 22985488)
1. Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes.
Ruggeri RM; Campennì A; Giovinazzo S; Saraceno G; Vicchio TM; Carlotta D; Cucinotta MP; Micali C; Trimarchi F; Tuccari G; Baldari S; Benvenga S
Thyroid; 2013 Feb; 23(2):239-42. PubMed ID: 22985488
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan.
Nishihara E; Amino N; Maekawa K; Yoshida H; Ito M; Kubota S; Fukata S; Miyauchi A
Endocr J; 2009; 56(6):791-8. PubMed ID: 19550078
[TBL] [Abstract][Full Text] [Related]
3. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gαs genes in a mild to moderate iodine-deficient Caucasian population.
Vicchio TM; Giovinazzo S; Certo R; Cucinotta M; Micali C; Baldari S; Benvenga S; Trimarchi F; Campennì A; Ruggeri RM
J Endocrinol Invest; 2014 Jul; 37(7):625-30. PubMed ID: 24789540
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain.
Palos-Paz F; Perez-Guerra O; Cameselle-Teijeiro J; Rueda-Chimeno C; Barreiro-Morandeira F; Lado-Abeal J; ; Araujo Vilar D; Argueso R; Barca O; Botana M; Cabezas-Agrícola JM; Catalina P; Dominguez Gerpe L; Fernandez T; Mato A; Nuño A; Penin M; Victoria B
Eur J Endocrinol; 2008 Nov; 159(5):623-31. PubMed ID: 18694911
[TBL] [Abstract][Full Text] [Related]
6. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma in an autonomous hyperfunctioning thyroid nodule: case report and review of the literature.
Tfayli HM; Teot LA; Indyk JA; Witchel SF
Thyroid; 2010 Sep; 20(9):1029-32. PubMed ID: 20718686
[TBL] [Abstract][Full Text] [Related]
8. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.
Niepomniszcze H; Suárez H; Pitoia F; Pignatta A; Danilowicz K; Manavela M; Elsner B; Bruno OD
Thyroid; 2006 May; 16(5):497-503. PubMed ID: 16756473
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort.
Sancak S; Jaeschke H; Eren F; Tarcin O; Guellueoglu B; Sen LS; Sever Z; Gozu HI; Bircan R; Akalin S; Paschke R; Eszlinger M
Horm Metab Res; 2011 Jul; 43(8):562-8. PubMed ID: 21773967
[TBL] [Abstract][Full Text] [Related]
10. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis.
Trülzsch B; Krohn K; Wonerow P; Chey S; Holzapfel HP; Ackermann F; Führer D; Paschke R
J Mol Med (Berl); 2001; 78(12):684-91. PubMed ID: 11434721
[TBL] [Abstract][Full Text] [Related]
11. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma?
Gozu H; Avsar M; Bircan R; Sahin S; Ahiskanali R; Gulluoglu B; Deyneli O; Ones T; Narin Y; Akalin S; Cirakoglu B
Thyroid; 2004 Nov; 14(11):975-80. PubMed ID: 15671779
[TBL] [Abstract][Full Text] [Related]
12. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.
Collins MT; Sarlis NJ; Merino MJ; Monroe J; Crawford SE; Krakoff JA; Guthrie LC; Bonat S; Robey PG; Shenker A
J Clin Endocrinol Metab; 2003 Sep; 88(9):4413-7. PubMed ID: 12970318
[TBL] [Abstract][Full Text] [Related]
13. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey.
Gozu HI; Bircan R; Krohn K; Müller S; Vural S; Gezen C; Sargin H; Yavuzer D; Sargin M; Cirakoglu B; Paschke R
Eur J Endocrinol; 2006 Oct; 155(4):535-45. PubMed ID: 16990652
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.
Mon SY; Riedlinger G; Abbott CE; Seethala R; Ohori NP; Nikiforova MN; Nikiforov YE; Hodak SP
Diagn Cytopathol; 2018 May; 46(5):369-377. PubMed ID: 29516685
[TBL] [Abstract][Full Text] [Related]
15. Sensitive Sequencing Analysis Suggests Thyrotropin Receptor and Guanine Nucleotide-Binding Protein G Subunit Alpha as Sole Driver Mutations in Hot Thyroid Nodules.
Stephenson A; Eszlinger M; Stewardson P; McIntyre JB; Boesenberg E; Bircan R; Sancak S; Gozu HI; Ghaznavi S; Krohn K; Paschke R
Thyroid; 2020 Oct; 30(10):1482-1489. PubMed ID: 32284013
[No Abstract] [Full Text] [Related]
16. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
17. Follicular variant of papillary carcinoma presenting as a hyperfunctioning thyroid nodule.
Gabalec F; Svilias I; Plasilova I; Hovorkova E; Ryska A; Horacek J
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e94-6. PubMed ID: 24072237
[TBL] [Abstract][Full Text] [Related]
18. Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer.
Uludag M; Yetkin G; Citgez B; Isgor A; Basak T
Hormones (Athens); 2008; 7(2):175-9. PubMed ID: 18477556
[TBL] [Abstract][Full Text] [Related]
19. Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.
Buryk MA; Simons JP; Picarsic J; Monaco SE; Ozolek JA; Joyce J; Gurtunca N; Nikiforov YE; Feldman Witchel S
Thyroid; 2015 Apr; 25(4):392-400. PubMed ID: 25627462
[TBL] [Abstract][Full Text] [Related]
20. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
